FIELD: biotechnologies.
SUBSTANCE: invention relates to the biotechnology. Disclosed is a method of purifying the recombinant receptor antagonist interleukin-36. Method of purifying the recombinant receptor antagonist IL-36 involves successively carrying out lysis of cells of the producer strain, ion-exchange chromatography and hydrophobic chromatography. In one embodiment of the method, negative anion-exchange chromatography is used as an ion-exchange chromatography, in another embodiment, cation-exchange chromatography.
EFFECT: invention allows to produce IL-36RA preparation with protein output of 34–57 % of initial amount of protein in biomass of producer strain, purity of not less than 95 % of total amount of protein by RP-HPLC and fraction of deamidated form of protein less than 5 % of total amount of protein.
3 cl, 13 dwg, 3 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
THE METHOD OF PRODUCTION OF INTERLEUKIN-36 RECEPTOR ANTAGONIST WITH CLEAVED N-TERMINAL METHIONINE, ESCHERICHIA COLI BL21[DE3] STRAIN PRODUCING INTERLEUKIN-36 RECEPTOR ANTAGONIST WITH CLEAVED N-TERMINAL METHIONINE (VARIANTS), METHOD OF THEIR CONSTRUCTION, PLASMID VECTORS pBAD15A AND pET15A AND DNA SEQUENCE FOR THEIR CONSTRUCTION | 2017 |
|
RU2672816C9 |
PLASMID VECTOR PRH15A FOR PRODUCING METHIONINE-FREE INTERFERON ALPHA-2B, BACTERIAL STRAIN ESCHERICHIA COLI BL21 DE3 - PRODUCER OF METHIONINE-FREE INTERFERON ALPHA-2B AND METHOD FOR PRODUCING METHIONINE-FREE INTERFERON ALPHA-2B | 2017 |
|
RU2697375C2 |
METHOD OF INDUSTRIAL PURIFICATION OF ROMIPLOSTIM | 2021 |
|
RU2804622C2 |
METHOD OF PRODUCING A PEPTIDE WHICH MODULATES PURINERGIC RECEPTOR ACTIVITY | 2019 |
|
RU2714114C1 |
METHOD FOR PRODUCING A HIGHLY PURIFIED RECOMBINANT HUMAN C1-ESTERASE INHIBITOR FOR APPLICATION IN MEDICINE | 2020 |
|
RU2769201C2 |
METHOD FOR OBTAINING ALPHA5-INTERFERON PROTEIN | 2011 |
|
RU2575598C9 |
METHOD FOR PRODUCTION OF ACTIVE PHARMACEUTICAL SUBSTANCE OF RECOMBINANT BISMETIONILYSTONE H1.3 | 2016 |
|
RU2634408C1 |
METHOD FOR PREPARING GENETIC-ENGINEERING HUMAN INSULIN | 2006 |
|
RU2322504C1 |
METHOD OF PREPARATION OF RECOMBINANT ANTAGONIST OF HUMAN INTERLEUKINE-1 RECEPTOR "ARIL" | 2004 |
|
RU2326947C2 |
METHOD OF PRODUCING RECOMBINANT BETA-N-ACETYLGLUCOSAMINIDASE StrH FROM STREPTOCOCCUS PNEUMONIAE | 2018 |
|
RU2693660C1 |
Authors
Dates
2019-09-19—Published
2018-04-13—Filed